Exact Sciences Announced That A District Court Judge Denied In Part Geneoscopy's (Defendant) Motion To Dismiss A Patent Infringement Lawsuit Filed By Exact Sciences (Plaintiff) In The United States District Court For The District Of Delaware
Portfolio Pulse from Benzinga Newsdesk
Exact Sciences announced that a District Court Judge denied in part Geneoscopy's motion to dismiss a patent infringement lawsuit filed by Exact Sciences. This ruling allows Exact Sciences to seek relief for Geneoscopy's future infringement and false advertising related to its Cologuard colorectal cancer screening test.
May 21, 2024 | 10:21 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exact Sciences' lawsuit against Geneoscopy for patent infringement and false advertising will proceed, potentially leading to relief for future infringements related to its Cologuard test.
The court's decision to deny part of Geneoscopy's motion to dismiss strengthens Exact Sciences' position in the lawsuit. This could lead to potential financial relief and protection of its patented technology, positively impacting EXAS stock in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100